Debora Grasso, Hyllana C D Medeiros, Luca X Zampieri, Vanesa Bol, Pierre Danhier, Marike W van Gisbergen, Caroline Bouzin, Davide Brusa, Vincent Grégoire, Hubert Smeets, Alphons P M Stassen, Ludwig J Dubois, Philippe Lambin, Marie Dutreix, Pierre Sonveaux
The clinical management of head and neck squamous cell carcinoma (HNSCC) commonly involves chemoradiotherapy, but recurrences often occur that are associated with radioresistance. Using human SQD9 laryngeal squamous cell carcinoma cancer cells as a model, we aimed to identify metabolic changes associated with acquired radioresistance. In a top-down approach, matched radiosensitive and radioresistant SQD9 cells were generated and metabolically compared, focusing on glycolysis, oxidative phosphorylation (OXPHOS) and ROS production...
2020: Frontiers in Pharmacology